KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Depreciation & Amortization (CF): 2017-2025

Historic Depreciation & Amortization (CF) for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $6.0 million.

  • Twist Bioscience's Depreciation & Amortization (CF) fell 9.80% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year decrease of 20.93%. This contributed to the annual value of $24.9 million for FY2025, which is 20.93% down from last year.
  • Latest data reveals that Twist Bioscience reported Depreciation & Amortization (CF) of $6.0 million as of Q3 2025, which was down 1.01% from $6.1 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Depreciation & Amortization (CF) peaked at $8.5 million during Q3 2023, and registered a low of $2.5 million during Q1 2021.
  • Over the past 3 years, Twist Bioscience's median Depreciation & Amortization (CF) value was $7.0 million (recorded in 2023), while the average stood at $7.3 million.
  • Per our database at Business Quant, Twist Bioscience's Depreciation & Amortization (CF) surged by 99.60% in 2022 and then declined by 26.94% in 2025.
  • Twist Bioscience's Depreciation & Amortization (CF) (Quarterly) stood at $3.1 million in 2021, then soared by 68.00% to $5.3 million in 2022, then skyrocketed by 54.40% to $8.2 million in 2023, then decreased by 21.92% to $6.4 million in 2024, then decreased by 9.80% to $6.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $6.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.4 million in Q1 2025.